Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only

Disclaimer: All products are for laboratory research only and not for human or animal use or consumption. For in-vitro research by qualified professionals only

Blend Cagrilintide + Semaglutide

$119.90

Cagrilintide

CAS #: 1415456-99-3
Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight (M.W.): Approximately 4409 g/mol
Sequence: Modified peptide sequence; identity should be confirmed against lot-specific documentation

Semaglutide

CAS #: 910463-68-2
Molecular Formula: C₁₈₇H₂₉₁N₄₅O₅₉
Molecular Weight (M.W.): Approximately 4114 g/mol
Sequence: Modified 31-amino-acid peptide structure; detailed structural identity should be verified against product-specific analytical documentation

Blend Information

Blend CAS #: Not Applicable
Blend Formula: Not Applicable
Blend Molecular Weight: Not Applicable
Blend Sequence: Not Applicable

VIEW COA

Description

Cagrilintide + Semaglutide Blend is a multi-component research formulation containing two chemically distinct peptide-based materials. Each component possesses its own molecular structure, chemical identity, and analytical profile.

Because this product is a mixture rather than a newly defined single molecular entity, do not assign one CAS Registry Number, molecular formula, molecular weight, or peptide sequence to the combined blend. Document each component independently.

This formulation is intended for controlled scientific research involving peptide characterization, analytical comparison, molecular interactions, biochemical systems, and related non-clinical research models.

Research Context

Cagrilintide is a modified peptide analogue with a complex lipidated structure, while semaglutide is a modified peptide containing structural features beyond a simple linear amino-acid sequence.

In research environments, the two materials may be examined independently or within defined multi-component experimental systems. Any scientific findings should remain specific to the study design, analytical conditions, and experimental model being used.

Do not interpret any laboratory observation as establishing therapeutic efficacy, clinical effectiveness, safety for human use, or suitability for consumer applications.

Analytical Identification

Because the blend contains two separate molecular entities, appropriate analytical characterization should distinguish each component individually.

Relevant quality documentation may include:

  • Component identity
  • Blend composition
  • Relative component amounts
  • Purity specifications
  • Chromatographic characterization
  • Molecular or mass-based analysis
  • Lot and batch identification
  • Certificate of Analysis

Take the actual ratio of Cagrilintide to Semaglutide directly from the product label or lot-specific Certificate of Analysis.

Specifications & Documentation

Confirm product specifications using current lot documentation rather than generic reference values. Differences in salt form, counter-ion, moisture content, or analytical basis can affect reported molecular characteristics.

For Cagrilintide specifically, reference databases recognize different salt forms separately, so verify the exact material form before using molecular data for analytical calculations.

Storage & Handling

Store according to the conditions provided on the product label and Certificate of Analysis. Maintain appropriate laboratory controls and protect the material from environmental conditions that could compromise its analytical integrity.

Limit handling to qualified research personnel using established laboratory procedures.

Research Use Only

This blend is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, medical, or clinical claims are made or implied. All information is supplied solely for scientific identification, documentation, and research reference.

Additional information

dose

5mg + 5mg

Reviews

There are no reviews yet.

Be the first to review “Blend Cagrilintide + Semaglutide”

Your email address will not be published. Required fields are marked *